Intestinal microbiota: A potential diet-responsive prevention target in ApcMin mice

Molecular Carcinogenesis

Volumn 46, Issue 1, 2007, Pages 42-48

  Mai, Volker ^a   Colbert, Lisa H ^b   Perkins, Susan N ^c,d   Schatzkin, Arthur ^c   Hursting, Stephen D ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Cancer; Colorectal; Microflora; Nutrition

Indexed keywords

DNA 16S; OLIVE OIL; PLANT EXTRACT;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIUM IDENTIFICATION; CALORIC RESTRICTION; CARCINOGENESIS; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DIET SUPPLEMENTATION; DNA SEQUENCE; FIBER; FLUORESCENCE IN SITU HYBRIDIZATION; FREEZE DRYING; FRUIT; INTESTINE ADENOMA; INTESTINE FLORA; INTESTINE POLYP; INTESTINE TUMOR; LACHNOSPIRACEAE; LIPID DIET; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VEGETABLE;

ADENOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; BACTERIA; COLONY COUNT, MICROBIAL; DIET; FRUIT; GASTROINTESTINAL TRACT; GENES, APC; IN SITU HYBRIDIZATION, FLUORESCENCE; INTESTINAL NEOPLASMS; INTESTINAL POLYPS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT OILS; RNA, RIBOSOMAL, 16S; VEGETABLES;

BACTERIA (MICROORGANISMS); CLOSTRIDIALES; LACHNOSPIRACEAE; MUS; UNIDENTIFIED BACTERIUM;

EID: 33846218256     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20233     Document Type: Article

References (35)

1. Potter JD. Nutrition and colorectal cancer. Cancer Causes and Control 1996;7:127-146.
2. Tannock GW. Analysis of the intestinal microflora: A renaissance. Antonie Van Leeuwenhoek 1999;76:265-278.
3. Vaughan EE, Schut F, Heilig HG, Zoetendal EG, De Vos WM, Akkermans AD. A molecular view of the intestinal ecosystem. Curr Issues Intest Microbiol 2000;1:1-12.
4. Zoetendal EG, Collier CT, Koike S, Mackie RI, Gaskins HR. Molecular ecological analysis of the gastrointestinal microbiota: A review. J Nutr 2004;134:465-472.
5. Malinen E, Rinttila T, Kajander K, et al. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005;100:373-382.
6. Ley RE, Backhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005;102:11070-11075.
7. Orrhage KM, Annas A, Nord CE, Brittebo EB, Rafter JJ. Effects of lactic acid bacteria on the uptake and distribution of the food mutagen Trp-P-2 in mice. Scand J Gastroenterol 2002;37:215-221.
8. Debruyne PR, Bruyneel EA, Li X, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res 2001;480:359-369.
9. Blair RM, Appt SE, Franke AA, Clarkson TB. Treatment with antibiotics reduces plasma equol concentration in cynomolgus monkeys (Macaca fascicularis). J Nutr 2003;133:2262-2267.
10. McCracken VJ, Simpson JM, Mackie RI, Gaskins HR. Molecular ecological analysis of dietary and antibiotic-induced alterations of the mouse intestinal microbiota. J Nutr 2001;131:1862-1870.
11. Rafter J. Lactic acid bacteria and cancer: Mechanistic perspective. Br J Nutr 2002;88:S89-S94.
12. Steer T, Carpenter H, Tuohy K, Gibson GR. Perspectives on the role of the human gut microbiota and its modulation by pro- and prebiotics. Nutr Res Rev 2000;13:229-254.
13. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241.
14. Hawk ET, Viner JL, Umar A. Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials. Prog Exp Tumor Res 2003;37:210-242.
15. Mai V. Dietary modification of the intestinal microbiota. Nutr Rev 2004;62:235-242.
16. Moser AR, Shoemaker AR, Connelly CS, et al. Homozygosity for the Min allele of Apc results in disruption of mouse development prior to gastrulation. Dev Dyn 1995;203:422-433.
17. Shoemaker AR, Gould KA, Luongo C, Moser AR, Dove WF. Studies of neoplasia in the Min mouse. Biochim Biophys Acta 1997;1332:F25-F48.
18. Jacoby RF, Marshall DJ, Newton MA, et al. Chemoprevention of spontaneous intestinal adenomas in the Apc Min mouse model by the non-steroidal anti-inflammatory drug piroxicam. Cancer Res 1996;56:710-714.
19. Paulsen JE, Elvsaas IK, Steffensen IL, Alexander J. A fish oil derived concentrate enriched in eicosapentaenoic and docosahexaenoic acid as ethyl ester suppresses the formation and growth of intestinal polyps in the Min mouse. Carcinogenesis 1997;18:1905-1910.
20. Mahmoud NN, Carothers AM, Grunberger D, et al. Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 2000;21:921-927.
21. Mai V, Colbert LH, Berrigan D, et al. Calorie restriction and diet composition modulate spontaneous intestinal tumorigenesis in Apc(Min) mice through different mechanisms. Cancer Res 2003;63:1752-1755.
22. Colbert LH, Mai V, Perkins SN, et al. Exercise and intestinal polyp development in APCMin mice. Med Sci Sports Exerc 2003;35:1662-1669.
23. Franks AH, Harmsen HJ, Raangs GC, Jansen GJ, Schut F, Welling GW. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998;64:3336-3345.
24. Harmsen HJ, Wildeboer-Veloo AC, Grijpstra J, Knol J, Degener JE, Welling GW. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000;66:4523-4527.
25. Harmsen HJ, Raangs GC, He T, Degener JE, Welling GW. Extensive set of 16S rRNA-based probes for detection of bacteria in human feces. Appl Environ Microbiol 2002;68:2982-2990.
26. Manz W, Amann R, Ludwig W, Vancanneyt M, Schleifer KH. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996;142:1097-1106.
27. Langendijk PS, Schut F, Jansen GJ, et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995;61:3069-3075.
28. Harmsen HJM, Elferich P, Schut F, Welling GW. A 16S rRNA-targeted probe for detection of Lactobacilli and Enterococci in faecal samples by fluorescent in situ hybridization. Microbial Ecology in Health and Disease 1999;11:3-12.
29. Poulsen LK, Licht TR, Rang C, Krogfelt KA, Molin S. Physiological state of Escherichia coli BJ4 growing in the large intestines of streptomycin-treated mice. J Bacteriol 1995;177:5840-5845.
30. Miller DN, Bryant JE, Madsen EL, Ghiorse WC. Evaluation and optimization of DNA extraction and purification procedures for soil and sediment samples. Appl Environ Microbiol 1999;65:4715-4724.
31. Zoetendal EG, Akkermans AD, De Vos WM. Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria. Appl Environ Microbiol 1998;64:3854-3859.
32. Guarner F, Malagelada JR. Gut flora in health and disease. Lancet 2003;361:512-519.
33. Finegold SM, Attebery HR, Sutter VL. Effect of diet on human fecal flora: Comparison of Japanese and American diets. Am J Clin Nutr 1974;27:1456-1469.
34. Hill MJ. Diet and the human intestinal bacterial flora. Cancer Res 1981;41:3778-3780.
35. Henderson AL, Cao WW, Wang RF, Lu MH, Cerniglia CE. The effect of food restriction on the composition of intestinal microflora in rats. Exp Gerontol 1998;33:239-247.